Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
BioXcel Therapeutics Announces Pricing of Public Offering of Common Stock
-
BioXcel Therapeutics (BTAI) to Offer 2M Shares of Common Stock
-
BioXcel Therapeutics Announces Proposed Public Offering of Common Stock
-
Commencement of Normal Course Issuer Bid
-
EML Payments Ltd (EML:AU) (EMCHF) PT Raised to AUD5.35 at Canaccord Genuity, Following Earnings
-
Blue Apron (APRN) PT Lowered to $5 at Canaccord Genuity, Following Earnings
-
UPDATE: Canaccord Genuity Downgrades Fluor (FLR) to Hold
-
Dynatrace Inc. (DT) Announces Proposed 25M Share Common Offering by Selling Shareholder
-
Dynatrace Launches Follow-On Offering by Selling Stockholders
-
Net Asset Value(s)
-
Pre-Open Stock Movers 02/18: (LM) (BEN) (AAP) Higher; (FLR) (CAG) (CVU) Lower (more...)
-
Coronavirus threatens Apple supply chain, sales; shares drop
-
REPEAT/Halo Labs Agrees to $12 Million Purchase of KushBar Retail Cannabis Business and 5 Permitted Store Locations in Alberta, Canada
-
Cluny Capital Announces Signing of Definitive Amalgamation Agreement With Xebra Brands Ltd. for Proposed Qualifying Transaction
-
Canaccord Genuity Downgrades CPI Aerostructures (CVU) to Hold
-
Sustainable Infrastructure Dividend Fund Files Final Prospectus
-
Halo Labs Agrees to $12 Million Purchase of KushBar Retail Cannabis Business and 5 Permitted Store Locations in Alberta, Canada
-
Inter-Rock Announces Normal Course Issuer Bid For Common Shares
-
CI Financial Corp. (CIX:CN) (CIFAF) PT Raised to Cdn$29 at Canaccord Genuity
-
Millrock Closes Non-Brokered Private Placement Financing
-
Sierra Wireless (SWIR) PT Lowered to $12 at Canaccord Genuity
-
Fidelity National Information Services (FIS) PT Raised to $178 at Canaccord Genuity
-
DexCom (DXCM) PT Raised to $300 at Canaccord Genuity
-
Brookfield Asset Management (BAM) PT Raised to $71.50 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Downgrades CryoLife (CRY) to Hold
-
TransGlobe Energy Corporation Announces Update to Significant Shareholder
-
Generac Holdings (GNRC) PT Raised to $113 at Canaccord Genuity, Following Earnings
-
Canaccord Genuity Upgrades IPH Limited (IPH:AU) to Buy, Following Earnings
-
Agios Pharma (AGIO) PT Lowered to $72 at Canaccord Genuity
-
TZP Group Exits Water Cooler Group / Media Storm
-
Transaction in Own Shares
-
Manitou Gold Announces Closing of Private Placement, Alamos Gold Maintains Interest
-
Velocity Closes Non-Brokered Private Placement For Gross Proceeds of $5.78 Million
-
Canaccord Genuity Downgrades Pretivm Resources (PVG:CN) (PVG) to Hold, Following Earnings
-
OZ Minerals (OZL:AU) (OZMLF) PT Raised to AUD10.65 at Canaccord Genuity
-
Ninepoint Partners Announces First Closing of Ninepoint 2020 Flow-Through Limited Partnership
-
Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Lowered to AUD4.10 at Canaccord Genuity, Following Earnings
-
Charter Hall Social Infrastructure REIT (CQE:AU) (FKKEF) PT Raised to AUD3.54 at Canaccord Genuity, Following Earnings
-
Shopify (SHOP:CN) (SHOP) PT Raised to $600 at Canaccord Genuity, Following Earnings
-
Palatin Technologies (PTN) PT Lowered to $3 at Canaccord Genuity, Following Earnings Release
-
Appen Ltd. (APX:AU) (APPEF) PT Raised to AUD28.30 at Canaccord Genuity, Before Earnings Release
-
Beach Energy Ltd (BPT:AU) (BEPTF) PT Lowered to AUD2.23 at Canaccord Genuity, Following Earnings
-
GenMark Diagnostics (GNMK) PT Lowered to $9 at Canaccord Genuity, Following Announcement of CEO Transition
-
Net Asset Value(s)
-
Synacor and Qumu Agree to Merger, Creating Global Leader in SaaS-Based Collaboration Software
-
Synacor (SYNC) and Qumu (QUMU) Announces Merger
-
Synacor and Qumu Agree to Merger, Creating Global Leader in SaaS-Based Collaboration Software
-
Acreage Announces Completion of Previously Announced Private Placement
-
Cortexyme Announces Closing of $125 Million Private Placement
-
Canaccord Genuity Starts Akero Therapeutics (AKRO) at Buy

